News

Learn simple strategies to help picky eaters enjoy a balanced Thanksgiving meal through planning, involvement, and a relaxed holiday atmosphere.

Can you guess the diagnosis?

A prepandemic NHANES analysis found no significant differences in fruit, vegetable, or overall diet quality between WIC participants and eligible nonparticipants.

Druhan Howell highlighted that pediatric patients using tapinarof cream experienced rapid symptom relief and improved quality-of-life measures, with no new safety concerns.

The investigational compound centanafadine to treat ADHD in children, adults, and adolescents, is a first-in-class NDSRI.

FDA approves Itvisma for patients 2 years and older with SMA, making it the first FDA-approved gene replacement therapy for this population.

The patient's physical exam is notable for a tan colored lesion on the left eye that Mom states has been present since birth. Can you guess the diagnosis?

The clearnace was granted to the Ceribell System for electrographic seizure detection in newborns pre-term and older.

George Rodgers, III, MD, PhD, emphasized that antithrombin III’s expanded pediatric label provides "a sterile, plasma-derived product that will specifically correct the deficiency in a more safe fashion."

Experts discuss how specialty pharmacy partnerships dramatically improved GLP-1 access, adherence, and workflow efficiency for teens with obesity.

A phase 1b study of zelpultide alfa demonstrated a favorable safety profile and encouraging early reductions in BPD and ventilation duration, supporting advancement to a pivotal international Phase 2b/3 program.

The CDC website now claims "studies supporting a link [between vaccines and autism] have been ignored by health authorities."

The agency approved a monthly dosing option for select patients acorss all approved indications, including wAMD, DME, DR, and RVO.

Alice Hoyt, MD, FAAAI, discussed the Early Childhood Anaphylaxis Collaborative’s efforts to improve anaphylaxis preparedness in early childcare settings.

Genetic testing in at-risk children can improve monitoring, guide activity choices, reduce stress, and prepare families for future therapies.

"What is the possibility for your individual child that you're taking care of as a patient, as a family member advocate?" said Oliva Kim-McManus, MD.

“This label expansion helps close a long-standing gap in the treatment of pediatric patients with hereditary antithrombin deficiency,” said George M. Rodgers, III, MD, PhD.

In this interview from the 2025 Child Neurology Society meeting, Olivia Kim-McManus explains how far the gene therapy and genetic testing space has come related to pediatric neurology.

The target action date for roflumilast cream 0.3% for plaque psoriasis in children 2 to 5 years is set for June 29, 2026.

Long-term data show sustained survival, immune recovery, and metabolic correction after lentiviral gene therapy for ADA-SCID, with no vector-related safety events.

National CPS data from 2012-2023 show declines in confirmed child maltreatment, but disparities remained, particularly among Black and female children.

FDA adds boxed warning to Elevidys and limits use to ambulatory DMD patients ≥4 years after reports of fatal acute liver failure in non-ambulatory patients.

Sub-analysis of ADORING trials shows VTAMA cream improved skin clearance, symptoms, and patient-reported outcomes in children aged 2-17.

A review found no link between prenatal acetaminophen exposure and offspring neurodevelopmental disorders.

Valeria C. Cohran, MD, emphasized the importance of close collaboration between intestinal rehab programs and general pediatricians to optimize care for children with intestinal failure.

Older age, longer remaining intestine, and presence of an ileocecal valve were linked with a greater likelihood of achieving sustained enteral autonomy in children with short bowel syndrome-associated intestinal failure.